20 participants
A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-08-31
- Start Date:
- 2020-09-30
- Completion:
- 2023-09-30
Conditions
- Squamous Cell Carcinoma
Interventions
- DRUG
No Results Yet